Porta Finance advises Medilink on sale of its diagnostics supply business to Roche

Porta Finance acted as an exclusive financial adviser to Latvian medical equipment distributor Medilink in relation to sale of its Roche diagnostics solutions and Sysmex haematology solutions distribution business to Roche Latvija, fully owned subsidiaryof Roche Group.

Medilink is among the leading medical equipment distribution companies in Latvia having strong relations with most of the largest healthcare institutions in Latvia. Following the transaction Medilink will continue operations of its non-Roche diagnostics business. Completion of the transaction is subject to the approval of Latvian Competition Council.

Roche Group is the world’s largest biotech company, headquartered in Basel, Switzerland, and active in over 100 countries and in 2017 employed about 94,000 people worldwide.

Porta Finance advised the shareholders of Medilink on all aspects of the transaction, including initial valuation, discussions with the investor, coordination of due diligence and negotiations in relation to transaction documentation.

Further information:

Mikus Janvars
Partner, Porta Finance
Tel: +371 6733 6730
mikus.janvars@portafinance.com